Recombinant Microbial Lipase SLV339: Clinical Trials

1 trial of Recombinant Microbial Lipase SLV339, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Recombinant Microbial Lipase SLV339: new trials by email Literature Review of Recombinant Microbial Lipase SLV339 trials Research Report on Recombinant Microbial Lipase SLV339

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis
Placebo, Recombinant Microbial Lipase SLV339 - Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis
Phase 2TerminatedSolvay Pharmaceuticals562008-02-012009-08-06

Conditions studied

Exocrine Pancreatic Insufficiency (1)  ·  Pancreatitis, Chronic (1)

Sponsors

Solvay Pharmaceuticals (1)

Countries

Czechia (1)  ·  Denmark (1)  ·  Hungary (1)  ·  Latvia (1)  ·  Poland (1)  ·  Russia (1)  ·  Sweden (1)